Navigation Links
Mirena Lawsuits Mount in New Jersey Litigation, as Number of Cases Filed Exceeds 960, Bernstein Liebhard LLP reports
Date:8/9/2014

New York, New York (PRWEB) August 09, 2014

Mirena lawsuits (http://www.drugbot.com/mirena-iud/lawsuit/) that allege IUD migration caused some users to suffer serious injuries continue to mount in the multicounty litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a new Case List issued in the litigation on August 4th, at least 960 cases have been filed in Bergen County. The new number indicates that more than 40 Mirena IUD lawsuits were added in the litigation since the previous Case List was released in July, when 928 filings were noted.

“Our Firm hears from alleged victims of serious Mirena complications related to IUD migration on a regular basis. We are not surprised that the number of filings continues to grow,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who were seriously harmed, allegedly due to spontaneous migration of the IUD.

Mirena IUD Lawsuit Allegations
According to court documents, all of the complaints pending in New Jersey claim that Bayer Healthcare Pharmaceuticals failed to adequately warn that the IUD could spontaneously migrate from its proper position in the uterus, even after it had been correctly inserted by a healthcare provider. Plaintiffs in Mirena lawsuits further allege that this occurrence caused a variety of serious injuries, including uterine perforations, organ damage, scarring, and infertility. Among other things, the claims point out that the labeling for the birth control device only warns that migration might occur if the uterus is punctured during its insertion.

Court records indicate that in addition to the claims pending in New Jersey, an additional 612 Mirena lawsuits involving similar allegations have been filed in a federal multicounty litigation now underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

The Mirena IUD is a long-acting contraceptive device that was first approved by the U.S. Food & Drug Administration (FDA) in 2000. It is inserted directly into the uterus by a healthcare provider, where it releases a synthetic progesterone for up to five years. In 2009, its approved uses were expanded to include the treatment of heavy menstrual bleeding in women who wish to use an IUD for birth control. In December 2009, the FDA also issued a warning letter to Bayer Healthcare Pharmaceuticals after finding that one of its Mirena promotions overstated the IUD’s benefits and downplayed its risks.

Alleged victims of serious Mirena complications related to spontaneous IUD migration may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more about the process for filing a Mirena lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential Mirena case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.drugbot.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/miren-iud-lawsuit/mirena-complications/prweb12083659.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mirena IUD Lawsuit News: New Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports
2. Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports
3. DrugNews Adds Latest Court Updates on Mirena IUD Lawsuits
4. Nearly 780 Mirena IUD Lawsuits Now Filed in New Jersey Litigation, Bernstein Liebhard LLP Reports
5. Mirena IUD Lawsuit Allowed to Proceed in State Court, After Judge Rules Certain Healthcare Defendants Weren’t Misjoined, Bernstein Liebhard LLP Reports
6. Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in New Jersey Mirena Lawsuits
7. Bernstein Liebhard LLP Notes Filing of New Mirena Lawsuit Alleging Spontaneous IUD Migration, other Complications
8. Mirena IUD Lawsuit News: Rising Popularity of Mirena May Be Cause for Concern, Reports Bernstein Liebhard LLP
9. Mirena IUD Birth Control Device Perforates Nevada Woman's Uterus Prompting Need for Removal Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
10. Mirena Lawsuits Continue to Mount, As Bernstein Liebhard LLP Notes Filing of New Claim on Behalf of Alleged Victim of Mirena Complications
11. DrugNews: Judge Refuses Bayer Request to Dismiss Mirena Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: